Literature DB >> 26059072

The cutoffs and performance of glycated hemoglobin for diagnosing diabetes and prediabetes in a young and middle-aged population and in an elderly population.

Shuang-Tong Yan1, Hai-Ying Xiao1, Hui Tian2, Chun-Lin Li1, Fu-Sheng Fang1, Xiao-Ying Li3, Xiao-Ling Cheng1, Nan Li1, Xin-Yu Miao1, Yan Yang1, Liang-Chen Wang1, Xiao-Man Zou4, Fang-Ling Ma4, Yao He5, Xiao-Yong Sai5.   

Abstract

The aims were to compare the appropriate cutoffs of glycated hemoglobin (HbA1c) in a population of varying ages and to evaluate the performance of HbA1c for diagnosing diabetes and prediabetes. A total of 1064 participants in the young and middle-aged group and 1671 in the elderly group were included and underwent HbA1c testing and an oral glucose tolerance test (OGTT). Sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) were calculated to evaluate the optimal HbA1c cutoffs. Kappa coefficients were used to test for agreement between HbA1c categorization and OGTT-based diagnoses. The optimal HbA1c cutoffs for diagnosing diabetes were 5.7% (39 mmol/mol) in the young and middle-aged group with a sensitivity of 66.7%, specificity of 86.7%, and AUC of 0.821 (95% CI: 0.686, 0.955) and 5.9% (41 mmol/mol) in the elderly group with a sensitivity of 80.4%, specificity of 73.3%, and AUC of 0.831 (0.801, 0.861). The optimal cutoffs for diagnosing prediabetes were 5.6% (38 mmol/mol) and 5.7% (39 mmol/mol) in the young and middle-aged group and in the elderly group, respectively. Agreement between the OGTT-based diagnosis of diabetes or prediabetes and the optimal HbA1c cutoff was low (all kappa coefficients <0.4). The combination of HbA1c and fasting plasma glucose increased diagnostic sensitivities or specificities. In conclusion, age-specific HbA1c cutoffs for diagnosing diabetes or prediabetes were appropriate. Furthermore, the performance of HbA1c for diagnosing diabetes and prediabetes was poor. HbA1c should be used in combination with traditional glucose criteria when detecting and diagnosing diabetes or prediabetes.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Diabetes; Diagnosis; Glycated hemoglobin; Prediabetes

Mesh:

Substances:

Year:  2015        PMID: 26059072     DOI: 10.1016/j.diabres.2015.05.047

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  6 in total

1.  PERFORMANCE OF A1C VERSUS OGTT FOR THE DIAGNOSIS OF PREDIABETES IN A COMMUNITY-BASED SCREENING.

Authors:  Jenny E Camacho; Vallabh O Shah; Ronald Schrader; Craig S Wong; Mark R Burge
Journal:  Endocr Pract       Date:  2016-08-02       Impact factor: 3.443

2.  Patterns of changes in fasting plasma glucose, hemoglobin A1c and the area under the curve during oral glucose tolerance tests in prediabetic subjects: results from a 16-year prospective cohort study among first-degree relatives of type 2 diabetic patients.

Authors:  Shahla Safari; Masoud Amini; Ashraf Aminorroaya; Awat Feizi
Journal:  Acta Diabetol       Date:  2020-10-21       Impact factor: 4.280

Review 3.  Update on pre-diabetes: Focus on diagnostic criteria and cardiovascular risk.

Authors:  Antonino Di Pino; Francesca Urbano; Salvatore Piro; Francesco Purrello; Agata Maria Rabuazzo
Journal:  World J Diabetes       Date:  2016-10-15

4.  A Consensus of Key Opinion Leaders on the Management of Pre-diabetes in the Asia-Pacific Region.

Authors:  Roberto Mirasol; Ah Chuan Thai; Aftab Ahmad Salahuddin; Kathryn Tan; Chaicharn Deerochanawong; Mafauzy Mohamed; Made Ratna Saraswati; Bipin Kumar Sethi; Sanjiv Shah; Nanny Natalia Soetedjo; Swangjit Suraamornkul; Rima Tan; Farid Uddin
Journal:  J ASEAN Fed Endocr Soc       Date:  2017-05-05

5.  Comparison of Various Indices in Identifying Insulin Resistance and Diabetes in Chronic Spinal Cord Injury.

Authors:  Gary J Farkas; Phillip S Gordon; Nareka Trewick; Ashraf S Gorgey; David R Dolbow; Eduard Tiozzo; Arthur S Berg; David R Gater
Journal:  J Clin Med       Date:  2021-11-28       Impact factor: 4.241

6.  The bidirectional association of C-peptide with cardiovascular risk in nondiabetic adults and patients with newly diagnosed type 2 diabetes mellitus: a retrospective cohort study.

Authors:  Shuang-Tong Yan; Jing Sun; Zhao-Yan Gu; Xin-Yu Miao; Li-Chao Ma; Ban-Ruo Sun; Xiao-Min Fu; Hong-Zhou Liu; Guang Yang; Fu-Sheng Fang; Hong Li
Journal:  Cardiovasc Diabetol       Date:  2022-10-03       Impact factor: 8.949

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.